Cosentyx contains Secukinumab, 150mg, supplied as injection. Manufacturer: Novartis / Cipla. Therapeutic class: IL-17A Inhibitor.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.